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Abstract Maintenance of cellular homeostasis requires
tight and coordinated control of numerous metabolic
pathways, which are governed by interconnected networks
of signaling pathways and energy-sensing regulators. Au-
tophagy, a lysosomal degradation pathway by which the
cell self-digests its own components, has over the past
decade been recognized as an essential part of metabolism.
Autophagy not only rids the cell of excessive or damaged
organelles, misfolded proteins, and invading microorgan-
isms, it also provides nutrients to maintain crucial cellular
functions. Besides serving as essential structural moieties
of biomembranes, lipids including sphingolipids are in-
creasingly being recognized as central regulators of a
number of important cellular processes, including au-
tophagy. In the present review we describe how sphin-
golipids, with special emphasis on ceramides and
sphingosine-1-phosphate, can act as physiological regula-
tors of autophagy in relation to cellular and organismal
growth, survival, and aging.
Keywords Ceramide  Sphingosine-1-phosphate 
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Abbreviations
Atg Autophagy-related
BH3 Bcl-2 homology-3
BNIP3 BCL2/adenovirus E1B 19 kDa protein-
interacting protein 3
C.
elegans
Caernorhabditis elegans
C1P Ceramide-1-phosphate
CERT Ceramide transfer protein
CERS Ceramide synthase
CPTP Ceramide-1-phosphate transfer protein
dhCer Dihydroceramide
DFCP1 Double FYVE-containing protein 1
ER Endoplasmic reticulum
FAPP2 Four-phosphate adaptor protein 2
GLTP Glycolipid transfer protein
JNK c-Jun N-terminal protein kinase
LC3 Microtubule-associated protein 1 light chain 3
mTOR Mammalian target of rapamycin
NBR1 Neighbor of BRCA1 gene 1
PI3 K Phosphoinositide 3-kinase
PI(3)P Phosphatidylinositol-3-phosphate
PKB Protein kinase B
PP2A Protein phosphatase 2A
S.
cerevisiae
Saccharomyces cerevisiae
SPT Serine palmitoyltransferase
SPHK Sphingosine kinase
S1P Sphingosine-1-phosphate
TOR Target of rapamycin
TORC TOR complex
ULK1 Unc-51 like autophagy activating kinase 1
WIPI WD-repeat protein interacting with
phosphoinosides
Introduction
Autophagy is an intracellular degradation process, which is
highly conserved among all eukaryotes. The term itself,
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meaning self-eating, refers to the fact that cells generate
energy and cellular building blocks by degradation of its
own components. In that sense autophagy is a pro-survival
process, but in unfavorable situations autophagy can con-
tribute to cell death [1]. Sphingolipids were once regarded
as being merely structural elements in cell membranes.
Now this diverse group of lipids is recognized as important
mediators of cellular events, including autophagy, through
their roles as functional entities in cellular membranes and
as bioactive signaling molecules. Especially three sphin-
golipid species, ceramide, dihydroceramide (dhCer), and
sphingosine-1-phosphate (S1P), have emerged as being
important mediators of the autophagic pathway. They are
believed to function as a rheostat controlling the balance
between sphingolipid-induced autophagy and cell death
[2]. Furthermore, sphingolipids are also important regula-
tors of nutrient import from the extracellular environment
and autophagic flux [3, 4]. This review aims to describe the
interaction between autophagy and sphingolipid metabo-
lism. Furthermore, we address the importance of subcel-
lular localization of the sphingolipid species in this
interplay.
Autophagy-machinery and regulation
The term autophagy encompasses several different sub-
processes classified according to how the cargo is transported
to the lysosome, which include macroautophagy, microau-
tophagy, and chaperone-mediated autophagy. Macroau-
tophagy is the most prevalent form, and will accordingly be
referred to as autophagy hereafter.
The autophagic degradation pathway overall includes
five levels: (1) The formation of a double-membrane
structure (also denoted as the isolation membrane), (2)
encapsulation of intracellular cargo, (3) formation of the
mature autophagosome, (4) fusion with a lysosome, and (5)
lysosomal degradation of the cargo (Fig. 1). Each of these
critical steps are regulated and effected by a number of
AuTophaGy-related proteins (the Atgs), first identified and
described in yeast [5, 6], but since shown to have metazoan
orthologs [7]. These specific proteins, some of which form
complexes, each have their own role in the process of
autophagy. The most prominent of these will be discussed
briefly in the following section.
Without stimulation, autophagic activity is kept at a low
basal level, but can be induced by extracellular cues such as
stress, starvation, various pathologies, or by drug treatment.
One very central gatekeeper of autophagy initiation is the
target of rapamycin (TOR) complex, with the TOR kinase as
a central catalytically active entity. The TOR kinase
assembles into two structurally and functionally distinct
complexes, referred to as TOR complex 1 (TORC1) and 2
(TORC2) [8]. If not inhibited by amino acid starvation,
TORC1 inhibits the formation of the autophagosome at a
very early step, namely the formation of the isolation
membrane. By phosphorylation of Atg13, TORC1 prevents
the formation of the Unc-51 like autophagy activating kinase
1 (ULK1) complex (Fig. 1). In times of amino acid starva-
tion, TORC1 is inhibited [9] and ULK1 is free to phospho-
rylate Beclin-1, which in turn enhances the activity of
VPS34, a class III phosphoinositide 3-kinase (PI3K) situated
at the autophagosomal membrane. Hence, the formation of
phosphatidylinositol-3-phosphate (PI(3)P) at the au-
tophagosomal membrane is induced. This provides a plat-
form for the gathering of autophagosomal actors and recruits
PI(3)P-binding proteins like the Double FYVE-containing
protein 1 (DFCP1) and WD-repeat protein interacting with
phosphoinositides 1 and 2 (WIPI1 and WIPI2), which are
both required for full induction of autophagy [10, 11].
In order for the isolation membrane to form and elon-
gate, continuous recruitment and formation of cellular
membrane structures are required. The endoplasmic reti-
culum (ER), Golgi, mitochondria, plasma membrane, lipid
droplets, and ER-mitochondria contact sites have all been
suggested to provide lipids for the formation of the au-
tophagosomal isolation membrane [12–19]. The elongation
of the growing pre-autophagosomal structure requires
ubiquitination of Atg5 by the ubiquitin-like protein Atg12,
which is activated by the E1-like enzyme Atg7 and the E2-
like enzyme Atg10. The Atg12-Atg5 complex is subse-
quently linked to Atg16, forming a tetramer that dissociates
from the mature autophagosome, which is required for the
elongation process [20]. In a second ubiquitin-like reaction,
in which the E1-like enzyme Atg7 and the E2-like enzyme
Atg3 are involved, microtubule-associated protein 1A/1B-
light chain 3 (LC3) is cleaved by Atg4 to form LC3-I,
which is subsequently lipidated by the addition of phos-
phatidylethanolamine into LC3-II. LC3-II localizes both to
the outer and inner autophagic membrane where it resides
until degradation of the cargo and the inner autophagic
membrane. Once the autophagosome is formed and ma-
tured, it can fuse with either an endosome to form an
amphisome, which subsequently fuses with a lysosome, or
directly with a lysosome to form an autolysosome.
Although the precise molecular details underlying the fu-
sion event still remain to be fully elucidated, it is known
that the small GTP-binding protein named Rab7, the
SNARE syntaxin Stx17, and components of the homotypic
fusion and protein sorting (HOPS)-tethering complex serve
as important factors in the autophagosome-lysosome fusion
[21–23]. After the fusion and subsequent degradation of the
autophagosomal cargo, the resulting material is transported
back to the cytosol through lysosomal permeases, where it
can be reused for energy production or as molecular
building blocks [24].
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Autophagy was originally considered to be a non-
selective process, however during the past decade several
studies have proven that autophagy can be highly selective.
Indeed, proteins like nucleoporin p62 and Neighbor of
BRCA1 gene 1 (NBR1) function as cargo receptors se-
lectively collecting ubiquitinated substrates for au-
tophagosomal degradation. p62 binds directly to LC3 and
is degraded in parallel with the cargo, thus accumulating
when degradation is inhibited. Recently, selective degra-
dation of entire organelles such as lipid droplets, ER, mi-
tochondria, and peroxisomes has been described [25],
suggesting that autophagy can act specifically.
Whether autophagy is acting selectively or not, the
regulation of this delicate process is highly critical. Within
the past decade, it has become clear that sphingolipids serve
as important regulators of this process at several levels.
Sphingolipid metabolism
Sphingolipids comprise a large family of lipids, which dif-
fers structurally from other lipid species by containing
a sphingoid base as structural backbone. Sphingolipid
metabolism constitutes an interconnected network where
balancing of sphingolipid synthesis, turnover, and recycling
are carefully regulated according to cell response and fate.
This network revolves around ceramide as depicted in Fig. 2.
De novo synthesis of sphingolipids is initiated at the cy-
tosolic face of the ER membrane, where serine palmitoyl-
transferase (SPT) catalyzes the condensation of serine and
palmitoyl-CoA producing 3-ketodihydrosphinganine. Next,
3-ketodihydrosphinganine is reduced to produce the sphin-
goid base dihydrosphingosine (sphinganine), which along
with sphingosine, comprises the backbone of sphingolipids.
Besides sphinganine the yeast Saccharomyces cerevisiae (S.
cerevisiae) also produces phytosphingosine as a sphingoid
base. Ceramide synthases (CERS1-6) catalyze the N-acyla-
tion of sphingoid bases resulting in synthesis of ceramides.
The CERSs display different chain length specificities [26],
which adds to the complexity of sphingolipids. CERS1
prefers C18-CoAs, while CERS2 utilizes acyl-CoAs ranging
from C20 to C26. CERS3 shows preference towards the ul-
tra-long-chain acyl-CoAs (C26–36), whereas CERS4 has
specificity for C18- and C20-CoAs. CERS5 and CERS6 both
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Fig. 1 Ceramides and other sphingolipids regulate autophagy at
multiple levels. mTOR complex 1 (mTORC1) phosphorylates and
suppresses the ULK1 complex under nutrient-rich conditions. Upon
induction of autophagy, the ULK1 complex is activated by AMP-
activated protein kinase (AMPK) phosphorylation and by autophos-
phorylation to phosphorylate Beclin1, which promotes the formation
of the Vps34/PI3-kinase complex and hence generation of phos-
phatidylinositol-3-phosphate (PI(3)P). This recruits PI(3)P-binding
proteins like DFCP1 and WIPIs to the membrane and promotes the
formation of autophagosomes. The Atg12–Atg5–Atg16 complex is
required for conjugating phosphatidylethanolamine (PE) to LC3 for
its attachment to the autophagosomes and hence for elongation and
closure of the isolation membrane. Once complete, the outer
membrane of the autophagosome fuses with the lysosome, and the
material is degraded in the autolysosome by acidic hydrolases.
Ceramides (Cer) have been shown to reduce the abundance of nutrient
transporters in the plasma membrane resulting in lowered uptake of
nutrients, hence activation of AMPK, suppression of TORC1 activity,
and activation of autophagy. Ceramides also promote dissociation of
the Bcl2–Beclin1 complex and affect ER homeostasis and fusion
between autophagosomes and lysosomes. Moreover, ceramides have
also been shown to affect calpain-mediated cleavage of Atg5.
Sphingoid long-chain base phosphates have furthermore been shown
to induce autophagy
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primarily incorporate C16-CoAs. Ceramides can be phos-
phorylated to ceramide-1-phosphate (C1P), modified by
addition of phosphocholine to yield sphingomyelin, or be
glycosylated to produce a vast number of different glyco-
sylceramides. Ceramides can be resynthesized from sphin-
gosine or regenerated by recycling of glycosylceramides and
sphingomyelin, or by dephosphorylation of C1P [27]. Im-
portantly, while de novo synthesis of ceramides by CERSs
requires hours [28], generation of ceramides from the recy-
cling pathways, e.g. degradation of sphingomyelin, occurs
within minutes of activation [29]. Thus, immediate regula-
tion of cellular processes by ceramides and other sphin-
golipids may be mediated by salvaging pathways, whereas
de novo synthesis of sphingolipids may modulate long-term
cellular processes.
Compartmentalization of sphingolipids is controlled
by subcellular transport
The diversity of biomembranes is based on the vast
structural heterogeneity of lipid species and their subcel-
lular and asymmetric distribution. Such heterogeneity in
organelles and membrane leaflets is critical in modulating
the localization of membrane-bound proteins and their
functional properties. Sphingolipids in the plasma
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Fig. 2 Overview of sphingolipid metabolism. Central in the sphin-
golipid metabolism is ceramide. Ceramide is de novo synthesized at
the endoplasmatic reticulum (ER) with the condensation of serine and
palmitoyl-CoA by serine palmitoyltransferase (SPT) being the first
step. Further reduction and acylation by a ceramide synthase (CERS1-
6) yields dihydrosphingosine (dHSph), which after desaturation
results in the formation of ceramide. At the ER ceramide can be
modified into galactosylceramide (GalCer), yet the majority of
ceramide modification takes place at the Golgi in a manner depending
on their further utilization. At the Golgi ceramide is used in the
synthesis of sphingomyelin (SM) and glycosphingolipids in reactions
catalyzed by sphingomyelin synthase 1 (SMS1) and glycosphin-
golipid synthases (GCSs), respectively. From the Golgi, SM and
glycosphingolipids are transported to the plasma membrane (PM).
Here SM can be turned into ceramide again by the actions of secretory
and neutral sphingomyelinases (sSMase and nSMase, respectively).
The ceramide can then be metabolized into ceramide-1-phosphate
(C1P), sphingosine-1-phosphate (S1P), or be resynthesized back into
SM. Complex sphingolipids residing in the PM can also be used as a
pool for recycling of ceramide by entering the endolysosomal
pathway. In this pathway acid SMase (aSMase) and glycosidases
(GCase) produce ceramide, which in turn can be hydrolyzed into
sphingosine and reused in the synthesis of ceramide or be degraded by
phosphorylation into S1P followed by breakdown to hexadecenal and
ethanolamine-1-phosphate (EA1P). In the Golgi, ceramide kinase
(CERK) can phosphorylate ceramide thereby generating ceramide-1-
phosphate (C1P). Other abbrevations: 3KSR 3-ketosphinganine
reductase, CPP ceramide phosphatase, DES1 dihydroceramide desat-
urase 1, aCDase acid ceramidase, nCDase neutral ceramidase, SPHK
sphingosine kinase, aSMase acid sphingomyelinase, SPL S1P lyase,
S1PP sphingosine phosphate phosphatase
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membrane are normally exclusively found in the outer
leaflet of the bilayer, and form together with cholesterol
specific membrane microdomains [30, 31]. Such mi-
crodomains are laterally segregated regions, which arise as
a result of selective affinities between sphingolipids and
membrane proteins and presumably act as signaling plat-
forms [31–34].
The distribution of sphingolipids in cellular organelles is
far from uniform. It has become evident that sphingolipids
are compartmentalized according to their functions, and that
subcellular transport aids this sorting. The sorting initiates at
the ER from where ceramide must be transported to the Golgi
apparatus for further modification. Non-vesicular transport
of ceramide requires the ceramide transfer protein (CERT)
[35]. CERT has a preference for ceramide species containing
acyl chains shorter than C22, while CERT-mediated trans-
port of C22 and C24:1 ceramides, and of dhCer is sig-
nificantly less efficient [36, 37]. Together with the fact that
ceramides transported by CERT to the Golgi preferentially
are incorporated into sphingomyelin compared to gly-
cosphingolipids [38], this implies that CERT contributes to
the complexity and subcellular distributions of specific
sphingolipids. The restricted specificity of CERT also sug-
gests that alternative routes for intracellular trafficking of
ceramide must exist. Although not delineated in molecular
detail yet, such alternative routes may include vesicular
transport or be mediated through specific inter-organelle
contact sites [39, 40].
Recently, a novel lipid transfer protein was identified by
virtue of its ability to specifically transfer C1P between
membranes, thus named C1P transfer protein (CPTP) [41].
Despite poor sequence homology, CPTP shares a very
similar structural fold with glycolipid transfer protein
(GLTP). However, it does not bind glycosylated ceramides
like galactosylceramide and lactosylceramide as GLTP
does. CPTP is localized in the cytosol, but it is also asso-
ciated with the trans-Golgi network, nucleus, and plasma
membrane, and has been proposed to control C1P levels to
maintain proper Golgi organization and inflammatory re-
sponses [41].
Although it does not transport ceramides, the evolu-
tionary conserved GLTP has been shown to accelerate
transfer of both diacylglycerols- and sphingoid-based gly-
colipids between lipid membranes [42]. GLTP enables
intermembrane transfer of glucosylceramide, lactosylce-
ramide, galactosylceramide, sulfatide, and the gangliosides
GM1 and GM3, but not phosphatidylcholine, phos-
phatidylethanolamine, sphingomyelin, phosphatidyli-
nositol, cholesterol, and cholesterol oleate [43, 44]. Thus,
although its function is yet to be fully resolved, it has been
proposed that GLTP mediates the transfer of glycosylce-
ramides from the Golgi to the plasma membrane or func-
tions as an intracellular sensor of glycosphingolipids [45].
To this end, another member of the GLTP superfamily,
the four-phosphate adaptor protein 2 (FAPP2) has also
been shown to mediate intermembrane lipid transfer be-
tween the Golgi and the plasma membrane, and to be
crucial for synthesis of complex glycosphingolipids in the
Golgi network [46, 47]. The fact that cellular processes are
highly compartmentalized too, paves the way for the idea
of a very tight and local control of sphingolipid metabolism
in relation to regulation of cellular processes.
Sphingolipids and membrane fusion
Upon completion of the autophagic process, the au-
tophagosome fuses with the lysosome to form the au-
tolysosome, where sequestered organelles and proteins are
degraded by acidic lysosomal hydrolases. The efficiency of
this step depends on the cellular lipid composition, in-
cluding the level of cholesterol and other lipids [48]. Even
though sphingolipids have not directly been shown to af-
fect fusion of autophagosomes with lysosomes, accumu-
lating evidence suggests that this step also depends on
sphingolipids. For example, it has recently been shown that
myristate induces autophagy and autophagic flux in car-
diomyocytes in a sphingolipid- and CERS5-dependent
way, indicating that ceramide synthesis is involved in
regulation of the autophagic flux [4]. Moreover, it has also
been suggested that progression of autophagy in yeast de-
pends on sphingolipid production. This is due to its role in
formation of autophagosomes rather than conjugation of
Atg12-Atg-5, lipidation of Atg8/LC3, maturation of vac-
uolar proteases, or the formation of the pre-autophagoso-
mal structure [49].
It has previously been shown that the production of C1P
from sphingomyelin, by the joint action of sphingomyeli-
nase and ceramide kinase, promotes Ca2?-dependent li-
posomal fusion, which enhances the vesicle fusion.
Interestingly, C1P levels increase during phagocytosis,
indicating that C1P may promote fusion between phago-
somes and lysosomes [50], and in turn signifying that C1P
regulates autophagosome-to-lysosome fusion as well.
Given the role of CPTP in controlling intracellular C1P
levels [41], CPTP may also control such fusion events.
Moreover, a recent study suggests a role for sphingosine
kinase 1 (SPHK1) and its product, S1P, in the endo-and
exocytotic membrane trafficking pathways [51], which are
tightly linked to the autophagic pathway [52, 53].
The heterogeneity in organelles and membrane leaflets
is, as previously mentioned, critical in modulating the lo-
calization of membrane-bound proteins and their functional
properties. Changes in membrane lipid species can alter the
membranes biophysical properties, which in turn affect
biological properties. Ceramide can induce rigidization of
662 Apoptosis (2015) 20:658–670
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membranes and hence may also affect the curvature of the
membrane [54]. Accordingly, acid sphingomyelinase-in-
duced synthesis of ceramide increases the packing of the
lipids and is associated with enhanced order in membranes
[55, 56]. It has been suggested that the hydrolysis of sph-
ingomyelin to ceramide within the inner leaflet of the
plasma membrane causes an outward curvature of the
membrane important for exocytosis [57]. This function of
membranous ceramide production may also apply to fusion
of autophagosomes with lysosomes. By analogy, homo-
typic vacuole fusion, which shares a number of compo-
nents with the fusion between autophagosomes and
lysosomes, has been suggested to be affected by ceramide
and other lipids in yeast [58, 59]. Moreover, sphingolipids
have been shown to support fusion of enveloped animal
viruses, such as Semliki Forest virus, with lipid bilayers
[60, 61], arguing that sphingolipids are important in
membrane fusion events.
In line with these studies, it has been found that an
increase in sphingosine and a concomitant decrease in S1P
are of pathological importance in the early events of the
lysosomal storage disorder, Niemann-Pick type C1. The
increase in sphingosine disturbs lysosomal Ca2? home-
ostasis, subsequently blocking the late endosome-to-lyso-
some transport [62]. Moreover, accumulation of
sphingomyelin is known to have a destabilizing effect on
lysosomes [63] and to result in leakage of the lysosomal
proteases to the cytosol [64]. A very recent study suggests
that the increased levels of sphingomyelin observed in
Niemann Pick disease type A, cause lysosomal dysfunction
due to lysosomal membrane permeabilization [65]. This
underlines that sphingolipids also function at another step
of the lysosomal degradation pathway.
Collectively, these studies reveal an additional function
of sphingolipids, besides their role as messenger molecules,
in the control of the autophagic and lysosomal degradation
pathways.
The pollice verso of sphingolipids
The regulation of the delicate balance between prolif-
eration and cell death is another important aspect where
sphingolipids act as second messengers. Specifically, S1P
and ceramide have proved important in the regulation of
cell fate [66, 67], however, their effect on cell fate are very
different [68, 69]. Both acting through autophagy, S1P is
believed to promote cell survival and proliferation, whereas
ceramide has been found to induce growth arrest and cell
death [70]. These opposing roles of two so easily inter-
convertible biomolecules have led to the manifestation of
the sphingolipid rheostat [2], which describes the intimate
balance between the intracellular levels of ceramide and
S1P and its importance in regulating cell fate (Fig. 3).
Furthermore, this sphingolipid rheostat is controlling cell
fate, at least partly, by modulating autophagy [67]. As the
conversion of ceramide to S1P only requires two steps [69,
71], the regulation of the enzymes balancing the concen-
trations and localizations of ceramide and S1P, is rather
significant to cell fate.
In favor of cell survival, S1P has been observed as a
critical player through its induction of autophagy [66]. S1P
levels are balanced by their synthesis from sphingosine
catalyzed by SPHKs, their dephosphorylation catalyzed by
S1P phosphatases and phosphohydratases as well as their
irreversible degradation catalyzed by S1P lyase (Fig. 2).
Sphingosine, in turn, can be generated by hydrolysis of
ceramide catalyzed by the ceramidase and removed by
synthesis of ceramide by the action of the CERS. In
agreement with this, knockdown of the ER-residing S1P
phosphatase, the enzyme responsible for the degradation of
S1P, augments S1P levels and induces autophagy [72].
Two distinct isoforms of SPHK have been character-
ized: SPHK1 and -2 sharing five conserved domains;
however, their tissue distribution and developmental ex-
pression are distinct [73, 74]. SPHK1, which is cytosolic, is
activated by several external stimuli to specifically signal
growth and survival [69]. It has been recognized as a nu-
trient-sensitive regulator of autophagy [68], and starvation-
induced autophagy is dependent on SPHK1 activity, a
mechanism, which is conserved from yeast to mammals
[68, 75]. Through its production of S1P, SPHK1 is there-
fore considered pro-survival, and accordingly SPHK1 has
been shown to induce DNA transcription and cell prolif-
eration [76].
It is not clear whether S1P signaling acts through or
parallel to the mammalian TOR (mTOR) pathway in
regulating autophagy [68, 72]. In a study by Lavieu et al.
phosphorylation of two known downstream effectors of
mTOR was found to be induced as response to overex-
pression of SPHK1 [68]. However, down-regulation of S1P
phosphorylase-1, and thus the degradation of S1P, does not
affect phosphorylation of mTOR nor its downstream ef-
fectors [72, 77]. Surprisingly, several studies have de-
scribed S1P as an inhibitor of autophagy through activation
of the mTOR pathway via specific S1P receptors in the
plasma membrane [67, 78–80]. However, it is important to
note that S1P signaling through cell surface receptors
might differ from signaling within the cell.
The class III PI3K inhibitor, 3-methyladenine, which is
known to prevent the formation of autophagosomes, does
not affect S1P induced autophagy, whereas silencing of
Atg5, a protein required at a later step in the autophagic
process, does indeed inhibit S1P-induced autophagy [72].
This might either suggest that S1P is controlling the au-
tophagic state through an entirely different signaling
Apoptosis (2015) 20:658–670 663
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pathway, or that S1P is able to interact directly with the
class III PI3K, preventing its inhibition by 3-methylade-
nine. In turn, the effect of S1P on cell survival is believed
to be conducted through an inositol-independent Ca2?
mobilization from intracellular stores [81], activation of the
mitogen activated protein pathway through the extracellu-
lar signal-regulated kinase ERK [82], and by suppression
of the apoptotic effect of ceramide via inhibition of the
stress-activated protein kinase c-Jun N-terminal protein
kinase (JNK) [2].
Surprisingly, the other isoform of the kinase responsible
for S1P production, SPHK2, is pro-apoptotic and has been
found to localize in both the nucleus and cytosol, where it
prevents DNA synthesis and cell proliferation, thus coun-
teracting the positive effect of SPHK1 on cell division [83,
84]. Upon starvation SPHK2 is redirected to the ER, which
is essential for its pro-apoptotic function [85]. Due to this
re-localization, it has been suggested that SPHK2’s pro-
apoptotic role is due to indirect production of ceramide
from external sources of sphingoid bases by the combined
actions of SPHK2 and lipid phosphohydrolases in the ER
[69, 85]. Accordingly, down-regulation of SPHK2 reduces
the conversion of sphingosine to ceramide via the recycling
pathway, whereas down-regulation of SPHK1 increases it
[85]. Interestingly, targeting of the pro-survival SPHK1 to
the ER makes it pro-apoptotic [85], collectively suggesting
that differently distributed intracellular pools of S1P might
participate in different metabolic and signaling pathways.
The death-inducing mitochondrial protein BCL2/adeno-
virus E1B 19 kDa protein-interacting protein 3 (BNIP3) is
involved in ceramide-induced cell death and can displace
Beclin 1 from the Beclin 1/Bcl-2 complex due to its Bcl-2
homology-3 (BH3) domain [86, 87]. The fact that SPHK2
also contains a BH3 domain that enables it to displace
Beclin 1, supports the pro-apoptotic effect of SPHK2 [88].
In line with this, mutation of the BH3 domain causes
suppression of the SPHK2 induced apoptosis [89]. Ac-
cordingly, it has been suggested that SPHK2 functions
independently of its catalytic activity by production of S1P,
but rather through its ability to interact with Bcl-2 [88].
Ceramide orchestrates programmed cell death through
two different pathways referred to as type I and type II
programmed cell death. Type I programmed cell death,
apoptosis, is induced by increased ceramide levels [69].
The mechanisms for ceramide-induced apoptosis are nu-
merous, including activation of caspase-9 through inacti-
vation of protein kinase B (PKB), activation of Bad
through Ras and protein phosphatase 2A (PP2A), dephos-
phorylation of retinoblastoma gene product by the activa-
tion of protein phosphatase 1, as well as activation of
protein kinase Cf and ceramide activated protein kinase
[90–95].
Ceramide has not only been associated with apoptotic
cell death, but also with another type of cell death distinct
from apoptosis [96–98]. Whereas autophagy is normally
associated with protection of the cell, an alternative strat-
egy has been known for a decade, where cells consume
their own interior resulting in a programmed cell death
occurring independently of the apoptotic cell death [99].
This autophagic cell death is referred to as type II cell
death [100] and is caspase-independent and characterized
by a large number of autophagic vacuoles, early degrada-
tion of organelles, and preservation of cytoskeletal ele-
ments [100, 101], and by being independent of apoptosis
and can be rescued by autophagic inhibition [1]. Further-
more, type II cell death can occur in the absence of the pro-
apoptotic members of the Bcl-2 family [102]. It is activated
by ceramide via induction of autophagy through lowering
CELL DEATH CELL SURVIVAL
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SPHK1/2CERS
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Fig. 3 Sphingolipid-mediated regulation of cell death and survival.
Regulation of the subcellular synthesis and localization of sphin-
golipids is crucial for their pro-apoptotic or pro-survival roles.
Sphingosine kinase 2 (SPHK2)-dependent synthesis of sphingosine-1-
phosphate (S1P) at the ER has been shown to promote apoptosis,
while translocation of SPHK1 from the cytosol to the plasma
membrane promotes synthesis of S1P at the plasma membrane and
induces cell survival
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of the mitochondrial membrane potential, and by activation
of the transcription of BNIP3 [98].
Whereas ceramide-induced autophagy and cell death act
by activation of PP2A, thus inhibiting the pro-survival
PKB [103], and subsequently augment Beclin 1 accumu-
lation [1, 66], S1P promotes cell survival in a PKB-inde-
pendent manner [103]. Since the anti-apoptotic protein Bcl-
2 inhibits the function of Beclin 1 in the early stages of
autophagy [104], the dissociation of the Beclin-1/Bcl-2
complex is required for induction of autophagy. Yet, ce-
ramide has proved a potent inducer of this dissociation
[105]. The release of Beclin 1 from the complex can be
mediated by phosphorylation of Bcl-2 by the stress-acti-
vated JNK and is stimulated by supplementation of short-
chain ceramides or by enhancing de novo synthesis of
ceramide [105]. Accordingly, Beclin 1 mutation, which
disables the protein to bind Bcl-2, induces autophagy re-
sulting in cell death [104].
In contrast to the cell death-inducing effects of ceramide
described above, Demarchi et al. found that C2-ceramide
triggers an NF-rB dependent survival pathway, and that the
induction of pro-survival genes is dependent on the pro-
tease calpain [106]. Calpain is induced upon starvation
[107], inhibits apoptosis [108], and has been found to be
required for autophagy as well as for the pro-survival effect
of C2 ceramide [106, 109]. These opposing functions of
ceramide have recently been coined the autophagy paradox
[1], and have been suggested to function as a brake of the
ceramide-induced cell death [106]. However, these obser-
vations may also be due to the artificial effects caused by
the use of biologically irrelevant ceramides used in these
studies.
In yeast TORC2 positively controls the synthesis of
phytoceramide and dhCer [110]. Since ceramide, as de-
scribed above, controls the induction of type II pro-
grammed cell death through activation of autophagy, it
might seem rather conflicting that TORC2, which is
otherwise known to support growth, activates the synthesis
of ceramide. However, it is likely that phytoceramide and
dhCers exert effects different from ceramides. Indeed, the
action of ceramide and its analogs on cell death has been
shown to be specific among the different lipid species
[111]. The steady-state levels of sphingoid long-chain-
bases and their phosphorylated derivatives in yeast were
also shown to decrease in mutants lacking an ortholog of
the mammalian TORC2 component Rictor [110]. This
observation suggests that TORC2 might be involved in the
production of S1P as well, which has been shown to re-
verse ceramide-mediated apoptosis [2]. In fact, the
TORC2-dependent ceramide and S1P production might
work as a feedback loop since both lipids are activators of
autophagy, which is negatively regulated by TOR [68].
Since S1P is synthesized from recycling of ceramide [28],
ceramide synthesis is required for production of this pro-
survival second messenger. Interestingly, increasing levels
of dhCer in response to inhibition of sphingolipid delta(4)-
desaturase DES1 have been shown to delay the G1/S
transition of the cell cycle in an autophagy-dependent
manner, suggesting a pro-survival role for dhCer [112].
Regulation of nutrient uptake by sphingolipids
Sphingolipids not only constitute significant structural en-
tities in the plasma membrane, they also regulate the ac-
tivity and abundance of nutrient transporters, thus
indirectly affecting autophagy. Erdinger and co-workers
showed that addition of C2-ceramides diminishes the sur-
face abundance of the amino acid transferase, 4F2, result-
ing in impaired amino acid uptake, induced autophagy, and
decreased viability [3]. Supplementation of methyl pyru-
vate, a membrane-permeant derivative of pyruvate, re-
versed C2-ceramide-induced cell death and autophagy
independent of the surface abundance of 4F2, arguing that
C2-ceramides cause starvation-induced cell death [3].
Similarly, Rosales et al. recently demonstrated that sphin-
golipid-based drugs down-regulate nutrient transporters,
thereby inducing autophagy and killing cancer cells by
nutrient deprivation [113]. Interestingly, inhibition of
TORC1 in S. cerevisiae activates the nitrogen permease
reactivator 1 kinase, which phosphorylates and hence re-
lieves the inactivating effects of Orm1 and Orm2 on the
SPT, resulting in increased de novo synthesis of complex
sphingolipids. In turn, plasma membrane localization and
activity of the general amino acid permease Gap1 is
stimulated [114]. To this end, inhibition of SPT and com-
plex sphingolipid synthesis have been shown to inhibit
autophagy [49]. Moreover, when sphingolipid levels are
low, the two phosphoinositide PI4,5P(2) binding proteins
Slm1 and Slm2 recruit the kinases Ypk1 and Ypk2 to
TORC2 at the plasma membrane, where they are phos-
phorylated and activated by TORC2 and the kinases Pkh1
and Pkh2 [115, 116]. Ypk1 and Ypk2 subsequently phos-
phorylate Orm1 and Orm2, which relieves their inhibition
of SPT, thereby stimulating the synthesis of long-chain
bases and sphingolipids [116, 117]. Interestingly, the
ORMDL gene family encoding mammalian homologs of
Orm1 and Orm2 has also been found to repress SPT ac-
tivity and sphingolipid synthesis in mammalian cells in a
phosphorylation-dependent manner [118], indicating that
this regulatory mechanism is evolutionary conserved.
These observations imply that nutrient uptake, TORC ac-
tivities, and sphingolipid synthesis are coordinately
regulated. Zimmerman et al. recently found that TORC1-
and GSK3-dependent phosphorylation of Elo2 in S. cere-
visiae promotes very-long chain fatty acid synthesis, while
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impaired phosphorylation results in a profound decrease in
ceramide levels and a concomitant increase in the level of
phosphorylated long-chain bases. The increase in phos-
phorylated long-chain bases resulted in constitutive in-
duction of autophagy, which negatively affected cell
viability, which again could be prevented by inactivation of
the sphingoid long-chain base kinase Lcb4 [119].
Collectively, these observations suggest that import of
nutrients via specific transporters and permeases is sensi-
tive to changes in the sphingolipid level in the plasma
membrane, which in turn is carefully controlled by net-
works of kinases and phosphatases in an auto-regulatory
loop.
Lifespan and sphingolipids
It is widely accepted that autophagy and lifespan are tightly
linked [120–123]. Sphingolipids may therefore also affect
organismal and cellular lifespan by modulating autophagy.
Liu et al. have recently shown that both chemical- and
genetic-inhibition of SPT activity increase lifespan in S.
cerevisiae through reduced TORC1 activity and enhanced
autophagy [124, 125], arguing that sphingolipids modulate
lifespan. They also observed that lifespan extension in-
duced by both calorie restriction and inhibition of S6 ki-
nase was further augmented by myriocin in a dose-
dependent manner [125], suggesting that impaired de novo
sphingolipid synthesis induces longevity in parallel to
caloric restriction and S6 kinase inhibition. Consistently,
inhibition of TORC1 by rapamycin further enhanced
myriocin-induced longevity, underlining that inhibition of
sphingolipid synthesis synergistically with impaired
TORC1 activity can extend life span [124, 125]. In line
with this, inhibition of SPT1 activity in Caernorhabditis
elegans (C. elegans) slowed the development rate and
extended longevity [126]. Mosbech et al. recently found
that impaired sphingolipid synthesis in C. elegans, caused
by functional loss of the two ceramide synthases HYL-1
and LAGR-1, extended longevity in an autophagy-depen-
dent manner [127]. Interestingly, loss of HYL-2 and
LAGR-1 function had the opposite effect on lifespan, ar-
guing that unique sphingolipid species and/or tissue-
specific synthesis of sphingolipids are important in deter-
mining organismal longevity [127]. Moreover, C. elegans
lacking ceramide glucosyl transferases arrests at the first
larval stage which can be rescued by expression of ce-
ramide glucosyl transferases in the most anterior- and
posterior intestinal cells, implying that cell-specific syn-
thesis of glycosphingolipids are indispensable for growth
and survival [128]. In summary, lifespan and development
are under the control of sphingolipid metabolism, possibly
through regulation of autophagy.
Concluding remarks
Sphingolipids comprise a diverse group of lipid species,
which are highly interchangeable, and therefore constitute
an ideal second messenger. The exact mechanisms gov-
erning sphingolipid-mediated regulation of autophagy and
other cellular processes still remain enigmatic; however,
their roles in autophagy appear to be mediated at different
stages of the autophagic process. Sphingolipids constitute a
major part of the plasma membrane and by virtue of their
biophysical properties and interactions with membrane
proteins, sphingolipids and proteins cluster to form mi-
crodomains with unique regulatory functions. Alterations
in membrane sphingolipids can modulate the level and
activity of nutrient transporters [3, 113, 129, 130] and
therefore impair nutrient uptake and indirectly induce au-
tophagy. Sphingolipids may also affect autophagy by
regulating the assembly of the autophagic machinery, and
affect fusion between autophagosomes and lysosomes, ei-
ther by modulating the membrane properties, abundance of
fusogenic SNARE proteins, or acidification of the lyso-
somes [48, 58, 59, 131]. However, since specific sphin-
golipids like S1P modulate particular cellular processes,
while other closely related species may exert opposite ef-
fects [54, 132, 133], the enzymes responsible for their in-
terconversions serve central roles in regulation of cellular
metabolism and cell fate. It is therefore also critical that the
localization of sphingolipids in specific cellular compart-
ments is tightly controlled. Thus, intracellular transport of
sphingolipids by transfer proteins like CERT, CPTP,
FAPP2, and GLTP, is crucial for their regulatory
properties.
Considering the regulatory roles of sphingolipids in
autophagy, it is interesting that autophagy regulates sph-
ingolipid levels including ceramide levels [134] and mo-
bilization as well as storage of glycerolipids in lipid
droplets [19, 135, 136]. Collectively, this shows that au-
tophagy and lipid metabolism are coordinately controlled,
and underlines the importance of sphingolipids in
metabolic regulation. However, some of the reported ef-
fects of sphingolipids are based on short-chain ceramides,
which may have completely different effects from ce-
ramides produced in vivo. Therefore, rather than using
such non-natural ceramides, the roles of sphingolipids in
autophagy should be examined further via loss-of-function
and overexpression studies in genetically tractable model
systems. Such studies will broaden our understanding of
how sphingolipids affect specific stages of autophagy.
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